Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients

29 Aug 2020

Abstract excerpt

OBJECTIVE: There is a pressing need to identify and validate, minimally invasive, molecular biomarkers that will complement current practices and increase the diagnostic accuracy in Parkinson's disease (PD). Brain-enriched miRNAs regulate all aspects of neuron development and function; importantly, they are secreted by neurons in amounts that can be readily detected in the plasma. Τhe aim of the present study was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to MicroRNA in disease regulation
Share to Nuclear Receptors and Signaling
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32860338
DOI: 10.1002/acn3.51146

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patientsPMID 32860338Read ↗

Validation of Differentially Expressed Brain-Enriched microRNAs in the Plasma of Parkinson’s Disease PatientsSemantic proximity Read ↗

Plasma miRNA Biomarker Signatures in Parkinsonian SyndromesSemantic proximity Read ↗

Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's DiseaseSemantic proximity Read ↗

miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s diseaseSemantic proximity Read ↗

Regulatory miRNA–mRNA Networks in Parkinson’s DiseaseSemantic proximity Read ↗

MicroRNAs in Parkinson’s disease: A systematic review and diagnostic accuracy meta-analysisSemantic proximity Read ↗

Exosome-derived miR-128 is decreased in Parkinson’s patient plasma that maintains synaptic integrity and protects against both intrinsic and extrinsic pathways of neuronal apoptosis in models of Parkinson’s diseaseSemantic proximity Read ↗

Meta-analyses identify differentially expressed microRNAs in Parkinson’s diseaseSemantic proximity Read ↗

Serum Exosomal miRNAs as Biomarkers of Early Diagnosis and Progression in Parkinson's DiseaseSemantic proximity Read ↗

Integrated Analysis and Identification of Novel Biomarkers in Parkinson’s DiseaseSemantic proximity Read ↗

Multi-omic landscaping of human midbrains identifies neuroinflammation as major disease mechanism in advanced-stage Parkinson’s diseaseSemantic proximity Read ↗

Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson’s DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.